Sinovac ' s COVID-19 Vaccine 78% Effective in Late-Stage Trial in Brazil: Source Sinovac ' s COVID-19 Vaccine 78% Effective in Late-Stage Trial in Brazil: Source

A COVID-19 vaccine developed by China ' s Sinovac Biotech was 78% effective in a late-stage Brazilian trial and entirely prevented severe cases, a source said on Thursday, boosting Chinese efforts to catch up with Western vaccine makers.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news